ICU Medical

ICU Medical CROIC

The Cash Return on Invested Capital (CROIC) of ICU Medical (ICUI) as of Nov 22, 2026 is 2.61 %. In the previous year, Cash Return on Invested Capital (CROIC) was 3.46 % — a change of -24.45% (lower).

CROIC

2.61 %

YoY

-24.45%

Last updated:

Cash Return on Invested Capital (CROIC) of ICU Medical is 2025 2.61 % . Cash Return on Invested Capital (CROIC) of ICU Medical was 2024 3.46 % . It decreases by -24.45% lower compared to the previous year.

The ICU Medical CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
4.68 USD
Jan 1, 2019
-0.29 USD
Jan 1, 2020
7.87 USD
Jan 1, 2021
11.22 USD
Jan 1, 2022
-4.22 USD
Jan 1, 2023
1.90 USD
Jan 1, 2024
3.46 USD
Jan 1, 2025
2.61 USD
The ICU Medical CROIC history
YEARCROICYoY
2.61 %-24.45%
3.46 %+82.37%
1.90 %-144.89%
-4.22 %-137.63%
11.22 %+42.58%
7.87 %-2,798.45%
-0.29 %-106.23%
4.68 %-24.39%
6.19 %-37.50%
9.90 %+40.33%
7.06 %-16.66%
8.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ICU Medical Stock analysis

What does ICU Medical do? ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems. ICU Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICU Medical stock

Cash Return on Invested Capital (CROIC) of ICU Medical is 2.61 % in 2025.

Cash Return on Invested Capital (CROIC) of ICU Medical changed from 3.46 % to 2.61 %, representing a -24.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) ICU Medical since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s ICU Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ICU Medical

All Key Metrics — ICU Medical